Skip to main content

Table 2 Changes in gastrointestinal symptoms, Bristol stool scale, and metabolic acidosis in patients switched from sevelamer hydrochloride to bixalomer and in control patients

From: Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

 

Switch group, n = 24

 

Ctrl group, n = 84

 

Swich vs.Ctrl

Swich vs.Ctrl

 

Before

3 months

P value*

Before

3 months

P value*

P value** (Before)

P value** (3 months)

[Questionnaires]

        

Reflux

2.0 ± 2.9

1.3 ± 2.4

0.044

1.3 ± 2.5

0.9 ± 1.8

0.117

0.067

0.193

Stomach ache

1.1 ± 1.6

1.1 ± 2.0

1.000

0.8 ± 2.0

0.6 ± 2.0

0.422

0.057

0.122

Epigastric fullness

3.0 ± 3.2

1.9 ± 3.2

0.069

1.5 ± 2.1

1.3 ± 2.4

0.417

0.028

0.554

Constipation

3.0 ± 2.9

1.5 ± 2.0

0.004

2.1 ± 2.4

1.5 ± 2.0

0.073

0.143

0.855

Diarrhea

2.2 ± 2.4

1.7 ± 2.1

0.274

2.1 ± 2.3

1.4 ± 2.2

0.042

0.685

0.414

Total score

11.3 ± 10.5

7.5 ± 10.1

0.011

7.9 ± 9.4

5.7 ± 8.2

0.117

0.062

0.814

Bristol scale

4.1 ± 1.0

4.0 ± 1.0

0.704

4.4 ± 1.1

4.1 ± 1.1

0.083

0.209

0.594

[Blood gas analysis]

 

pH

7.36 ± 0.04

7.39 ± 0.04

0.004

    

HCO3-

19.7 ± 2.3

21.3 ± 3.2

0.028

    

BE (vt)

−5.0 ± 2.5

−3.3 ± 3.1

0.012

    

Anion Gap

19.6 ± 3.3

15.8 ± 3.1

0.000

    
  1. *, paired t test, **, Mann–Whitney U test.